Federal Register #2026-14939

USPTO Patent Extensions for Centanafadine Hydrochloride and Proposed Janitorial Services at CDC Fort Collins

This notice covers two distinct government actions: - The United States Patent and Trademark Office (USPTO), part of the Department of Commerce, has granted one-year interim extensions for the terms of four U.S. patents (Nos. 8,461,196; 9,737,506; 8,877,798; and 9,205,074) - These patents are related to the drug product centanafadine hydrochloride - Extensions are due to ongoing regulatory review by the Food and Drug Administration (FDA) - Each extension is for one year and may be renewed up to five times if needed - No OEMs or vendors are involved in the patent extension process - The Committee for Purchase From People Who Are Blind or Severely Disabled proposes to add janitorial services at the CDC Fort Collins Colorado Campus - ServiceSource, Inc. is named as the supplier for these janitorial services - The service will be provided at the CDC Fort Collins Colorado Campus, 3156 Rampart Road, Fort Collins, CO - No specific product part numbers or quantities are listed for the janitorial services - The patent extension is not a procurement action, but the janitorial service proposal is a potential procurement opportunity

Description

The United States Patent and Trademark Office has issued an order granting a one-year interim extension of the term of U.S. Patent No. 8,877,798 (the 798 patent). The patent claims the drug product centanafadine hydrochloride. The extension is granted because the regulatory review period for the drug product is ongoing before the Food and Drug Administration and is reasonably expected to extend beyond the original expiration date of the patent, July 25, 2026. This interim extension is granted under 35 U.S.C. 156(d)(5) for a period of one year from the original expiration date.

View original listing